Search research articles
Contact Us
Filters
Showing results (761-770 of 932) with videos related to
Page
of 94
Sort By:
Cancer
|
November 6, 2015
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Marina D Kaymakcalan, Wanling Xie, Laurence Albiges, et al.
JCO Precision Oncology
|
September 11, 2020
Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate Cancer
G Celine Han, Justin Hwang, Stephanie A M Wankowicz, et al.
Urology
|
January 28, 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients
Jesse D Sammon, Rana R McKay, Simon P Kim, et al.
Clinical Genitourinary Cancer
|
April 9, 2025
Osteoporosis Amongst Testicular Cancer Survivors: Long Term Follow-Up of the Veterans Affairs Health System
Nuphat Yodkhunnatham, Paul Riviere, Kshitij Pandit, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
Urologic Oncology
|
December 3, 2014
The burden of skeletal-related events in patients with prostate cancer and bone metastasis
Florian Roghmann, Carina Antczak, Rana R McKay, et al.
Cancers
|
May 25, 2024
Characterization of <i>FOLH1</i> Expression in Renal Cell Carcinoma
Eric Ovruchesky, Elizabeth Pan, Melis Guer, et al.
JAMA Network Open
|
March 20, 2024
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes
Rana R McKay, Tyler J Nelson, Meghana S Pagadala, et al.
JCO Global Oncology
|
February 29, 2020
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts
Dominick Bossé, Wanling Xie, Xun Lin, et al.
Molecular Cancer Therapeutics
|
February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Page
of 94
Search research articles
Search
Showing results (761-770 of 932) with videos related to
Sort By:
Page
of 94
Cancer
|
November 6, 2015
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Marina D Kaymakcalan, Wanling Xie, Laurence Albiges, et al.
JCO Precision Oncology
|
September 11, 2020
Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate Cancer
G Celine Han, Justin Hwang, Stephanie A M Wankowicz, et al.
Urology
|
January 28, 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients
Jesse D Sammon, Rana R McKay, Simon P Kim, et al.
Clinical Genitourinary Cancer
|
April 9, 2025
Osteoporosis Amongst Testicular Cancer Survivors: Long Term Follow-Up of the Veterans Affairs Health System
Nuphat Yodkhunnatham, Paul Riviere, Kshitij Pandit, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
Urologic Oncology
|
December 3, 2014
The burden of skeletal-related events in patients with prostate cancer and bone metastasis
Florian Roghmann, Carina Antczak, Rana R McKay, et al.
Cancers
|
May 25, 2024
Characterization of <i>FOLH1</i> Expression in Renal Cell Carcinoma
Eric Ovruchesky, Elizabeth Pan, Melis Guer, et al.
JAMA Network Open
|
March 20, 2024
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes
Rana R McKay, Tyler J Nelson, Meghana S Pagadala, et al.
JCO Global Oncology
|
February 29, 2020
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts
Dominick Bossé, Wanling Xie, Xun Lin, et al.
Molecular Cancer Therapeutics
|
February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Page
of 94